Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y4SO
|
||||
Former ID |
DNC014324
|
||||
Drug Name |
9-[9-(beta-Carboline-9-yl)nonyl]-beta-carboline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530824] | ||
Structure |
Download2D MOL |
||||
Formula |
C31H32N4
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C3=C(N2CCCCCCCCCN4C5=CC=CC=C5C6=C4C=NC=C6<br />)C=NC=C3
|
||||
InChI |
1S/C31H32N4/c1(2-4-10-20-34-28-14-8-6-12-24(28)26-16-18-32-22-30(26)34)3-5-11-21-35-29-15-9-7-13-25(29)27-17-19-33-23-31(27)35/h6-9,12-19,22-23H,1-5,10-11,20-21H2
|
||||
InChIKey |
JJAATQLWMKLMJU-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [530824] | |
WikiPathways | Irinotecan Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.